Vanguard Group Inc Syndax Pharmaceuticals Inc Transaction History

Vanguard Group Inc

  • $4.96 Trillion
  • Q1 2024

A detailed history of Vanguard Group Inc transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 4,926,984 shares of SNDX stock, worth $94.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,926,984
Previous 4,335,353 13.65%
Holding current value
$94.9 Million
Previous $93.7 Million 25.16%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$19.71 - $24.57 $11.7 Million - $14.5 Million
591,631 Added 13.65%
4,926,984 $117 Million
Q4 2023

Feb 14, 2024
BUY
$11.39 - $21.67 $8.18 Million - $15.6 Million
718,051 Added 19.85%
4,335,353 $93.7 Million
Q3 2023

Nov 14, 2023
BUY
$14.52 - $21.77 $502,856 - $753,938
34,632 Added 0.97%
3,617,302 $52.5 Million
Q2 2023

Aug 14, 2023
BUY
$19.35 - $22.31 $1.66 Million - $1.91 Million
85,585 Added 2.45%
3,582,670 $75 Million
Q1 2023

May 15, 2023
BUY
$20.66 - $28.98 $2.76 Million - $3.87 Million
133,635 Added 3.97%
3,497,085 $73.9 Million
Q4 2022

Feb 10, 2023
BUY
$20.64 - $26.24 $11.6 Million - $14.7 Million
561,151 Added 20.02%
3,363,450 $85.6 Million
Q3 2022

Nov 14, 2022
BUY
$18.51 - $24.79 $396,039 - $530,406
21,396 Added 0.77%
2,802,299 $67.3 Million
Q2 2022

Aug 12, 2022
BUY
$13.64 - $19.48 $4.75 Million - $6.79 Million
348,465 Added 14.33%
2,780,903 $53.5 Million
Q1 2022

May 13, 2022
BUY
$14.84 - $22.15 $1.41 Million - $2.11 Million
95,068 Added 4.07%
2,432,438 $42.3 Million
Q4 2021

Feb 14, 2022
BUY
$15.23 - $22.47 $2.56 Million - $3.77 Million
167,964 Added 7.74%
2,337,370 $51.2 Million
Q3 2021

Nov 12, 2021
BUY
$13.87 - $19.8 $841,326 - $1.2 Million
60,658 Added 2.88%
2,169,406 $41.5 Million
Q2 2021

Aug 13, 2021
BUY
$13.42 - $25.18 $28.3 Million - $53.1 Million
2,108,748 New
2,108,748 $36.2 Million

Others Institutions Holding SNDX

# of Institutions
195
Shares Held
90M
Call Options Held
353K
Put Options Held
207K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $1.09B
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email